trimetazidine has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilgi, C; Comert, B; Inal, V; Ocal, R; Tanoglu, A; Yamanel, L | 1 |
| Chaugai, S; Chen, C; Chen, J; Lai, J; Ning, Q; Ruan, G; Wang, DW; Yang, L | 1 |
2 other study(ies) available for trimetazidine and Blood Poisoning
| Article | Year |
|---|---|
Appreciation of trimetazidine treatment in experimental sepsis rat model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Glutathione Peroxidase; Interleukin-1beta; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Trimetazidine; Tumor Necrosis Factor-alpha | 2015 |
Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Bone Marrow Transplantation; Cardiotonic Agents; Cells, Cultured; Coculture Techniques; Cytokines; Heart; Heme Oxygenase-1; Lipopolysaccharides; Macrophages, Peritoneal; Male; Membrane Proteins; Mice, Inbred C57BL; NF-E2-Related Factor 2; Reactive Oxygen Species; Sepsis; Sirtuin 1; Trimetazidine | 2016 |